CDKL5 deficiency disorder and other infantile‐onset genetic epilepsies
Developmental Medicine & Child Neurology · 2024-04 · 66 (4) · 456-468
DOI: 10.1111/dmcn.15747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 28.09.2023. Verfasst von Carolyn Daniels und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Brain Diseases, Epilepsy, Epileptic Syndromes, Movement Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIMH NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Aim
To differentiate phenotypic features of individuals with CDKL5 deficiency disorder (CDD) from those of individuals with other infantile‐onset epilepsies.
Method
We performed a retrospective cohort study and ascertained individuals with CDD and comparison individuals with infantile‐onset epilepsy who had epilepsy gene panel testing. We reviewed records, updated variant classifications, and compared phenotypic features. Wilcoxon rank‐sum tests and χ 2 or Fisher's exact tests were performed for between‐cohort comparisons.
Results
We identified 137 individuals with CDD (110 females, 80.3%; median age at last follow‐up 3 year 11 months) and 313 individuals with infantile‐onset epilepsies (156 females, 49.8%; median age at last follow‐up 5 years 2 months; 35% with genetic diagnosis). Features reported significantly more frequently in the CDD group than in the comparison cohort included developmental and epileptic encephalopathy (81% vs 66%), treatment‐resistant epilepsy (95% vs 71%), sequential seizures (46% vs 6%), epileptic spasms (66% vs 42%, with hypsarrhythmia in 30% vs 48%), regression (52% vs 29%), evolution to Lennox–Gastaut syndrome (23% vs 5%), diffuse hypotonia (72% vs 36%), stereotypies (69% vs 11%), paroxysmal movement disorders (29% vs 17%), cerebral visual impairment (94% vs 28%), and failure to thrive (38% vs 22%).
Interpretation
CDD, compared with other suspected or confirmed genetic epilepsies presenting in the first year of life, is more often characterized by a combination of treatment‐resistant epilepsy, developmental and epileptic encephalopathy, sequential seizures, spasms without hypsarrhythmia, diffuse hypotonia, paroxysmal movement disorders, cerebral visual impairment, and failure to thrive. Defining core phenotypic characteristics will improve precision diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
- Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
- Children's Hospital Colorado, Aurora, CO, USA.
- Department of Pediatrics, University of Colorado, School of Medicine, Aurora, CO, USA.
- Department of Pharmacology, University of Colorado, School of Medicine, Aurora, CO, USA.
- Department of Neurology, University of Colorado, School of Medicine, Aurora, CO, USA.
ORCID-Profile: Carolyn Daniels, Timothy A Benke, Heather E Olson
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Daniels, C., Greene, C., Smith, L., Pestana-Knight, E., Demarest, S., Zhang, B., Benke, T. A., Poduri, A., Olson, H. E., & CDKL5 Study Group (2024). CDKL5 deficiency disorder and other infantile‐onset genetic epilepsies. Developmental Medicine & Child Neurology, 66(4), 456-468. https://doi.org/10.1111/dmcn.15747
Vancouver
Daniels C, Greene C, Smith L, Pestana-Knight E, Demarest S, Zhang B, et al. CDKL5 deficiency disorder and other infantile‐onset genetic epilepsies. Developmental Medicine & Child Neurology. 2024;66(4):456-468. doi:10.1111/dmcn.15747
BibTeX
@article{Daniels2024,
author = {Daniels, Carolyn and Greene, Caitlin and Smith, Lacey and Pestana-Knight, Elia and Demarest, Scott and Zhang, Bo and Benke, Timothy A and Poduri, Annapurna and Olson, Heather E and CDKL5 Study Group, CDKL5 Study Group},
title = {CDKL5 deficiency disorder and other infantile‐onset genetic epilepsies},
journal = {Developmental Medicine & Child Neurology},
year = {2024},
volume = {66},
number = {4},
pages = {456--468},
doi = {10.1111/dmcn.15747}
}
EUVIMED